Zytiga (Abiraterone)

This is a medication used to treat certain types of prostate cancer. It works by blocking the body's ability to make male hormones that fuel the cancer cells. It's often used for advanced prostate cancer that hasn't responded well to other treatments.

Brand names:Zytiga, Yonsa
Medication

What people taking Zytiga (Abiraterone) report

Every report comes from a Lived member, sent anonymously.

Have you tried Zytiga (Abiraterone) for Prostate Cancer?

NameHow it went

About Zytiga (Abiraterone)

What It's For

Abiraterone acetate, best known by the brand name Zytiga, is a prescription hormone therapy for prostate cancer that has spread beyond the prostate (metastatic prostate cancer). It is always taken together with a steroid, usually prednisone, and alongside ongoing testosterone-lowering treatment. It is approved for two situations. The first is castration-resistant prostate cancer, meaning the cancer keeps growing even though standard hormone therapy has brought testosterone down to very low levels. The second is high-risk castration-sensitive prostate cancer: cancer that has spread and still responds to hormone therapy, but has features such as many bone lesions or a high Gleason score (a measure of how aggressive the cancer cells look) that predict a faster course. In large trials, adding abiraterone lengthened survival in both groups. Generic abiraterone tablets and the brand Abirtega follow the same instructions as Zytiga. Yonsa is a different formulation of the same ingredient with its own dose and steroid partner. Akeega combines abiraterone with niraparib, a targeted drug, for men whose cancer carries a change in a BRCA gene, one of the genes cells use to repair damaged DNA.

How It Works

Prostate cancer usually depends on androgens, the male hormones such as testosterone, to grow. Standard hormone therapy, either injections that switch off the testicles' testosterone production or surgical removal of the testicles (orchiectomy), removes most of this supply. The adrenal glands and the tumor itself can still make smaller amounts, and that remaining supply can keep the cancer growing. Abiraterone blocks an enzyme called CYP17 that these tissues need to make androgens, so it cuts off the supply that standard therapy leaves behind. Blocking CYP17 also pushes the adrenal glands to make more of a hormone that holds on to salt and water. That is why it can raise blood pressure, lower potassium and cause swelling, and why it is paired with a low dose of steroid, which helps keep that effect in check.

Dosage & Administration

Abiraterone is a tablet taken by mouth once a day. For Zytiga, Abirtega and generic versions, the usual dose is 1,000 mg once daily, with prednisone taken once or twice a day depending on the type of cancer being treated. A lower dose is used for people with moderate liver problems, and the drug is not used when liver function is severely reduced. Zytiga and generic tablets must be taken on an empty stomach: no food for 2 hours before and 1 hour after the dose. Taking it with food raises the amount absorbed and can increase side effects. Swallow the tablets whole with water; do not crush or chew them. Yonsa is taken at 500 mg once daily with methylprednisolone instead of prednisone, and it can be taken with or without food. Because doses and food rules differ, the products are not swapped milligram for milligram. Keep taking the steroid and the testosterone-lowering injections as prescribed, and do not stop either without the care team. If you miss one dose of abiraterone or the steroid, take the normal dose the next day; if more than one day is missed, contact the care team.

Side Effects

Tiredness, joint pain or swelling, hot flashes, nausea, diarrhea, cough, colds and headaches are among the most common effects. Many overlap with the effects of the hormone therapy itself. Raised blood pressure, low potassium and fluid retention are expected possibilities, so these are checked at least monthly. Low potassium matters because it can trigger a dangerous heart rhythm. Contact the care team right away about muscle weakness or cramps, a fast or irregular heartbeat, dizziness or feeling faint, new swelling in the legs or feet, or shortness of breath. Abiraterone can also cause liver injury, which is occasionally severe and usually appears in the first three months. Contact the care team promptly about yellowing of the skin or eyes, dark urine, pain in the upper right part of the abdomen, or nausea, vomiting and loss of appetite with unusual tiredness.

Interactions & Warnings

Liver blood tests are checked before treatment starts, every two weeks for the first three months and monthly after that. If results rise too far, the dose is paused, lowered or stopped. Blood sugar and cholesterol can also change. The steroid taken with abiraterone matters for safety as well as comfort. Stopping or cutting it, or having a serious infection, surgery or other major stress, can lead to adrenal insufficiency, a shortage of the body's stress hormone that causes weakness, low blood pressure and vomiting. The care team may increase the steroid during these periods. Some medicines change how much abiraterone reaches the blood. Certain seizure medicines (phenytoin, carbamazepine, phenobarbital), the tuberculosis antibiotic rifampin and the herbal supplement St. John's wort can lower its level. Abiraterone can raise levels of some other drugs. People with diabetes who take pioglitazone or repaglinide have had severe low blood sugar and should monitor glucose closely. Starting abiraterone together with radium-223, an injected radioactive treatment for prostate cancer that has spread to bone, is not recommended because the combination increased fractures and deaths. Abiraterone can harm a developing baby. Men taking it whose partner could become pregnant should use effective contraception during treatment and for 3 weeks after the last dose. Anyone who is or may become pregnant should not handle the tablets without gloves. People with heart failure or other heart disease need closer monitoring.

What to Expect

Treatment usually continues for as long as the cancer stays controlled and side effects are manageable, which is often many months or years. Abiraterone is not a cure for metastatic prostate cancer; its purpose is to slow the cancer and extend life. The first few months involve frequent blood tests for liver function and potassium, plus blood pressure checks. After that, visits usually settle into a monthly rhythm. PSA (prostate-specific antigen, a blood marker of prostate cancer activity) is often followed, along with scans, although a change in PSA alone does not always reflect how well the drug is working for an individual. If the cancer starts growing again, other treatments such as chemotherapy or newer targeted therapies are considered.

Questions to Ask Your Doctor

  1. 1.Is my cancer castration-sensitive or castration-resistant, and what do you expect abiraterone to add for me?
  2. 2.How does abiraterone compare with other hormone-blocking pills or chemotherapy for my situation?
  3. 3.Which abiraterone product will I take, and how should I time it around meals and my steroid dose?
  4. 4.How often will my liver, potassium and blood pressure be checked, and which symptoms should prompt a call?
  5. 5.Do any of my current medicines, including diabetes or seizure medicines and supplements, need to change?

Last reviewed • Oct 2026

Educational content, not medical advice.